Luca Beldi

Luca Beldi

Auto-generated profile, based on publicly available information

Luca Beldi

Institute for Infectious Diseases, University of Bern, Bern, Switzerland

Research Focus & Metrics

Academic Career Length

7Years (2020-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
24 April 2020 in Nature Communications
Verified
Journal Article
Open access
PDF file
SPSimona P. Pfister
Simona P. Pfister
OSOlivier P. Schären
Olivier P. Schären
LBLuca Beldi
Luca Beldi
APAndrea Printz
Andrea Printz
MNMatheus D. Notter
Matheus D. Notter
SHSiegfried Hapfelmeier
Siegfried Hapfelmeier
There is the notion that infection with a virulent intestinal pathogen induces generally stronger mucosal adaptive immunity than the exposure to an avirulent strain. Whether the associated mucosal inflammation is important or redundant for effective induction of immunity is, however, still unclear. Here we use a model of auxotrophicSalmonellainfection in germ-free mice to show that live bacterial virulence factor-driven immunogenicity can be uncoupled from inflammatory pathogenicity. Although live auxotrophicSalmonellano longer causes inflammation, its mucosal virulence factors remain the main drivers of protective mucosal immunity; virulence factor-deficient, like killed, bacteria show reduced efficacy. Assessing the involvement of innate pathogen sensing mechanisms, we show MYD88/TRIF, Caspase-1/Caspase-11 inflammasome, and NOD1/NOD2 nodosome signaling to be individually redundant. In colonized animals we show that microbiota metabolite cross-feeding may recover intestinal luminal colonization but not pathogenicity. Consequent immunoglobulin A immunity and microbial niche competition synergistically protect againstSalmonellawild-type infection.

21 May 2025 in bioRxiv
Verified
Preprint
Open access
PDF file
LBLuca Beldi
Luca Beldi
YDYuan Dong
Yuan Dong
CVColin Volet
Colin Volet
DTDisha Tandon
Disha Tandon
KFKristýna Filipová
Kristýna Filipová
SHSiegfried Hapfelmeier
Siegfried Hapfelmeier
Secondary bile acids, generated through microbial transformation of primary bile acids secreted in bile, play a role in shaping intestinal microbial communities, modulating host immunity, and regulating energy metabolism. In vitro studies have shown that the balance between primary and secondary bile acids strongly affects spore germination, growth, and cellular physiology of Clostridioides difficile , a major nosocomial gut pathogen. In vivo correlations between microbiome composition, bile acid metabolome, and colonization resistance have led to the hypothesis that 7α-dehydroxylating bacteria such as Clostridium scindens protect against C. difficile infection by producing secondary bile acids like deoxycholic acid. However, due to the genetic intractability of known 7α-dehydroxylating species, direct experimental validation of this causal relationship has been challenging. In this study, we leveraged the first available 7α-dehydroxylation-deficient baiH mutant to test the direct role of 7-dehydroxylated bile acid production in C. difficile colonization resistance in vivo. We colonized gnotobiotic mice with isogenic wild-type or baiH strains of the recently described 7α-dehydroxylating species Faecalicatena contorta , including wild-type C. scindens -colonized mice as a positive control. Wild-type F. contorta accumulated 7-dehydroxylated bile acids at levels equivalent to C. scindens , in a strictly baiH -dependent manner. However, despite equivalent bile acid profiles, wild-type F. contorta failed to replicate the C. difficile -restrictive phenotype observed with C. scindens . These findings demonstrate that commensal clostridial 7α-dehydroxylation alone is not sufficient for enhancing colonization resistance to C. difficile . Our results highlight the existence of additional, potentially bile acid-independent mechanisms by which certain commensals mediate protection, with important implications for microbiota-based therapies. Importance: 7α-dehydroxylated secondary bile acids, including deoxycholic acid and lithocholic acid, produced by commensal clostridia are widely assumed to inhibit the important nosocomial pathogen Clostridioides difficile , yet their precise role in colonization resistance remains unresolved. Using a defined mouse microbiota and an isogenic Faecalicatena contorta strain pair differing in a single 7α-dehydroxylation gene ( baiH ), we show that restoration of secondary bile acid production is not sufficient to delay C. difficile colonization in vivo. This contrasts with the protective effect of Clostridium scindens , which generates a similar bile acid profile. Our findings uncouple bile acid metabolism from protection and suggest that additional, strain-specific functions – such as nutrient competition or antimicrobial production – play a critical role. Understanding these mechanisms is essential for the rational design of next-generation microbiota-based therapies to prevent or treat recurrent C. difficile infection.

29 January 2021 in Nature Communications
Verified
Journal Article
Open access
PDF file
SPSimona P. Pfister
Simona P. Pfister
OSOlivier P. Schären
Olivier P. Schären
LBLuca Beldi
Luca Beldi
APAndrea Printz
Andrea Printz
MNMatheus D. Notter
Matheus D. Notter
SHSiegfried Hapfelmeier
Siegfried Hapfelmeier
A Correction to this paper has been published: https://doi.org/10.1038/s41467-021-21096-5.